CMBA
RMD icon

C.M. Bidwell & Associates’s ResMed RMD Stock Holding History

C.M. Bidwell & Associates’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$290K Sell
1,293
-6
-0.5% -$1.5K 0.14% 92
2025
Q4 		$313K Sell
1,299
-46
-3% -$11.8K 0.15% 87
2025
Q3 		$368K Sell
1,345
-105
-7% -$28.7K 0.18% 77
2025
Q2 		$374K Sell
1,450
-76
-5% -$18.1K 0.19% 78
2025
Q1 		$342K Buy
1,526
+112
+8% +$26.1K 0.21% 83
2024
Q4 		$323K Sell
1,414
-23
-2% -$5.54K 0.2% 88
2024
Q3 		$351K Sell
1,437
-40
-3% -$8.94K 0.21% 77
2024
Q2 		$283K Sell
1,477
-6
-0.4% -$1.22K 0.19% 87
2024
Q1 		$294K Buy
+1,483
New +$272K 0.2% 92
2020
Q2 		– Sell
-2,177
Closed -$321K – 450
2020
Q1 		$321K Buy
+2,177
New +$347K 0.34% 77
2019
Q4 		– Sell
-2,915
Closed -$394K – 445
2019
Q3 		$394K Sell
2,915
-110
-4% -$14.4K 0.39% 72
2019
Q2 		$369K Buy
+3,025
New +$335K 0.37% 89
2017
Q2 		– Sell
-3,935
Closed -$283K – 367
2017
Q1 		$283K Buy
+3,935
New +$272K 0.06% 127
2016
Q2 		– Sell
-3,290
Closed -$190K – 307
2016
Q1 		$190K Sell
3,290
-35
-1% -$1.98K 0.05% 170
2015
Q4 		$179K Buy
+3,325
New +$187K 0.04% 168

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

C.M. Bidwell & Associates's RMD Position: Q1 2026 in Review

C.M. Bidwell & Associates reduced its ResMed (RMD) stake by 0.46% in Q1 2026, selling an estimated $1.5K and leaving 1,293 shares worth $290K. The position accounts for 0.14% of the portfolio, ranked #92.

C.M. Bidwell & Associates first reported a position in RMD in Q4 2015 and has held it in 15 quarters since. The position peaked at $394K in Q3 2019. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • C.M. Bidwell & Associates held 1,293 shares of ResMed worth $290K as of Q1 2026.
  • C.M. Bidwell & Associates sold 6 ResMed shares in Q1 2026, an estimated $1.5K.
  • ResMed made up 0.14% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #92 holding.
  • C.M. Bidwell & Associates first reported a position in ResMed in Q4 2015 and has held it in 15 quarters since.
  • C.M. Bidwell & Associates's ResMed position peaked at $394K in Q3 2019.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.